Literature DB >> 1819507

cdc25 M-phase inducer.

J Millar1, C McGowan, R Jones, K Sadhu, A Bueno, H Richardson, P Russell.   

Abstract

In this paper, we have described the critical experiments leading to the discovery and analysis of the cdc25 M-phase inducer. We have shown that timing of mitosis is sensitive to the level of cdc25+ expression and that the cellular concentration of p80cdc25 increases as cells approach mitosis. From these observations we conclude that, in S. pombe, rate of accumulation of p80cdc25 plays an important role in determining the timing of mitosis. We postulate that under a given set of conditions, a critical level of p80cdc25 activity is required to undergo mitosis. The actual level that is required can vary depending on ploidy, growth rate, nutritional status of the cell, and perhaps other parameters. These signals may be monitored through the weel pathway leading to tyrosyl phosphorylation of p34cdc2. We have shown that p80cdc25 encodes a phosphate that acts by directly dephosphorylating the Tyr-15 residue of p34cdc2. Our studies strongly indicate that this aspect of the mitotic control network is generally conserved among eukaryotes. It is conceivable, however, that the mode of regulation of cdc25 activity may vary from species to species. Clearly, in S. cerevisiae the cdc25+ homolog, MIH1, in contrast to cdc25+, is not rate-limiting for M-phase onset. It will be important to determine whether the level of cdc25+ homologs in other organisms also oscillates during the cell cycle, or whether their activity is controlled by localization or posttranslational mechanisms, such as phosphorylation. Furthermore, our finding of more than one cdc25+ homolog in a single species suggests an additional level of complexity to the control of M-phase onset by cdc25 in higher eukaryotes that will require further investigation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1819507     DOI: 10.1101/sqb.1991.056.01.065

Source DB:  PubMed          Journal:  Cold Spring Harb Symp Quant Biol        ISSN: 0091-7451


  8 in total

1.  The cell cycle Cdc25A tyrosine phosphatase is activated in degenerating postmitotic neurons in Alzheimer's disease.

Authors:  X L Ding; J Husseman; A Tomashevski; D Nochlin; L W Jin; I Vincent
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

2.  The role of the LH subdomain in the function of the Cip/Kip cyclin-dependent kinase regulators.

Authors:  Steve Otieno; Christy R Grace; Richard W Kriwacki
Journal:  Biophys J       Date:  2011-05-18       Impact factor: 4.033

3.  Dephosphorylation of cdc25-C by a type-2A protein phosphatase: specific regulation during the cell cycle in Xenopus egg extracts.

Authors:  P R Clarke; I Hoffmann; G Draetta; E Karsenti
Journal:  Mol Biol Cell       Date:  1993-04       Impact factor: 4.138

Review 4.  Regulation of the cell cycle by protein phosphatase 2A in Saccharomyces cerevisiae.

Authors:  Yu Jiang
Journal:  Microbiol Mol Biol Rev       Date:  2006-06       Impact factor: 11.056

5.  Cloning and characterization of a cdc25 phosphatase from mouse lymphocytes.

Authors:  J L Nargi; T A Woodford-Thomas
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

6.  Ectopic expression of the Drosophila Cdk1 inhibitory kinases, Wee1 and Myt1, interferes with the second mitotic wave and disrupts pattern formation during eye development.

Authors:  Donald M Price; Zhigang Jin; Simon Rabinovitch; Shelagh D Campbell
Journal:  Genetics       Date:  2002-06       Impact factor: 4.562

7.  PP2A inhibition from LB100 therapy enhances daunorubicin cytotoxicity in secondary acute myeloid leukemia via miR-181b-1 upregulation.

Authors:  Chao Hu; Mengxia Yu; Yanling Ren; Kongfei Li; Dominic M Maggio; Chen Mei; Li Ye; Juying Wei; Jie Jin; Zhengping Zhuang; Hongyan Tong
Journal:  Sci Rep       Date:  2017-06-06       Impact factor: 4.379

8.  Pyp3 PTPase acts as a mitotic inducer in fission yeast.

Authors:  J B Millar; G Lenaers; P Russell
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.